EAP & Limited Use
Exceptional Access Program (EAP)
EAP forms are to be completed when applying for MOH funding for drugs for rheumatological diseases through Ontario’s Exceptional Access Program (EAP).
EAP Forms and Downloads
Ankylosing Spondylitis (AS)
Juvenile Idiopathic Arthritis
Ocular Inflammatory Disease/Uveitis
Psoriatic Arthritis (PsA)
Rheumatoid Arthritis (RA)
Giant Cell Arteritis (GCA)
Limited Use Codes
Current LU codes are available online in a database maintained by the Ontario Ministry of Health.
Please visit: https://www.formulary.health.gov.on.ca/formulary/
Note that some drug products not listed on the Formulary are reimbursed through the Exceptional Access Program (EAP). Some drug products listed as a Limited Use benefit on the Formulary may be reimbursed through the EAP for other indications.
ORA Biosimilar Fact Sheet With Limited Use Codes
The ORA maintains a biosimilar fact sheet, complete with LU codes and helpful links. You may access the form here: Biosimilar-Fact-Sheet
NIHB Drug list
Here is a link to the Government of Canada’s Non-Insured Health Benenfits for First Nations and Inuit (NHIB) website.
The CRA has also developed NIHB resources that you may find useful. Link: Non-Insured Health Benefits (NIHB)
Note: Metoject Pre-Filled Syringes (for NIHB only)
MOHLTC IVIG Request Form
November 6, 2019:
The ORA EAP Committee continues to work with the MOHLTC on an approved EAP Form for GCA. We hope to have this completed as soon as possible. A notice will be sent to members once it is available. Thank you for your patience.